Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-04-2013 | Letter to the Editor

Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a ¹²³I-FP-CIT SPECT study

Authors: Roberto Erro, Sabina Pappatà, Paolo Barone, Maria Teresa Pellecchia

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 4/2013

Excerpt

Dear Sir, …

Di Giuda D, Camardese G, Bentivoglio AR, Cocciolillo F, Guidubaldi A, Pucci L, et al. Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. 2012;39:1937–48. doi:10.1007/s00259-012-2232-7.PubMedCrossRef

Erro R, Pappatà S, Amboni M, Vicidomini C, Longo K, Santangelo G, et al. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson’s disease patients. Parkinsonism Relat Disord. 2012;18:1034–8. doi:10.1016/j.parkreldis.2012.05.022.PubMedCrossRef

Foster PS, Drago V, Crucian GP, Sullivan WK, Rhodes RD, Shenal BV, et al. Anxiety and depression severity are related to right but not left onset Parkinson’s disease duration. J Neurol Sci. 2011;305:131–5.PubMedCrossRef

Title: Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study
Authors: Roberto Erro
Sabina Pappatà
Paolo Barone
Maria Teresa Pellecchia
Publication date: 01-04-2013
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 4/2013
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-012-2300-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a ¹²³I-FP-CIT SPECT study

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2013

Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia

Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI)

Interim FDG PET/CT as a prognostic factor in diffuse large B-cell lymphoma

Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT study: reply to comment by Erro et al.

Predicting tumour response to chemoradiotherapy in oesophageal cancer by early interim 18F-FDG PET: where do we stand and where should we go?

Microalbuminuria predicts silent myocardial ischaemia in type 2 diabetes patients